223 related articles for article (PubMed ID: 6366700)
1. [Relation between estrogen and progesterone receptors and response to hormone therapy].
Leclercq G; Paridaens R; Heuson JC
Pathol Biol (Paris); 1983 Dec; 31(10):793-800. PubMed ID: 6366700
[TBL] [Abstract][Full Text] [Related]
2. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
Clavel B; Gest J
Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
[TBL] [Abstract][Full Text] [Related]
3. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
[TBL] [Abstract][Full Text] [Related]
4. Steroid receptors in breast cancer.
Desombre ER
Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
[TBL] [Abstract][Full Text] [Related]
5. Hormone receptors and Japanese breast cancer.
Matsumoto K; Kitamura Y; Sugano H
Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
[TBL] [Abstract][Full Text] [Related]
6. [Progesterone receptors in breast cancer].
Vitola GIa; Zeĭkate GA; Grabovska IK
Vopr Onkol; 1987; 33(9):35-8. PubMed ID: 3660754
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of hormone receptors in the treatment of breast neoplasms in women].
Delarue JC; Bohuon C
Ann Biol Clin (Paris); 1980; 38(5):293-6. PubMed ID: 7469145
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of steroid hormone receptors in the management of primary and advanced breast cancer.
McGuire WL
Eur J Cancer (1965); 1980; Suppl 1():39-43. PubMed ID: 7032943
[No Abstract] [Full Text] [Related]
9. [Breast cancer--topics from basic research].
Matsumoto K; Kuroda H; Takeyama M
Gan To Kagaku Ryoho; 1984 May; 11(5):974-80. PubMed ID: 6721515
[TBL] [Abstract][Full Text] [Related]
10. [A case of male breast cancer with special reference to the hormonal environment during chemoendocrine therapy].
Saito K; Hotta T; Kobayashi S; Miura I; Sakuma S; Shimozato T; Torii T; Iwase H; Satake A; Nishida T
Gan No Rinsho; 1985 Oct; 31(13):1727-30. PubMed ID: 3001383
[TBL] [Abstract][Full Text] [Related]
11. [Steroid hormone receptors in breast cancer (a review of the literature)].
Korolev VI; Dziubko NIa; Tarutinov VI
Vrach Delo; 1988 Nov; (11):86-91. PubMed ID: 2853492
[No Abstract] [Full Text] [Related]
12. [Value of hormone therapy in metastasizing breast cancer].
Samonigg H
Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
[TBL] [Abstract][Full Text] [Related]
13. Ratio of concentrations of estrogen receptors to progesterone receptors (ER/PR) in the cytosol of breast cancers (stratification by forming of groups differing in PR).
Hochmann J
Neoplasma; 2007; 54(4):290-6. PubMed ID: 17822318
[TBL] [Abstract][Full Text] [Related]
14. Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients.
Loven D; Rakowsky E; Stein JA; Geier A; Lunenfeld B
Isr J Med Sci; 1981; 17(9-10):960-4. PubMed ID: 7309485
[TBL] [Abstract][Full Text] [Related]
15. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
De Maeyer L; Van Limbergen E; De Nys K; Moerman P; Pochet N; Hendrickx W; Wildiers H; Paridaens R; Smeets A; Christiaens MR; Vergote I; Leunen K; Amant F; Neven P
J Clin Oncol; 2008 Jan; 26(2):335-6; author reply 336-8. PubMed ID: 18182677
[No Abstract] [Full Text] [Related]
16. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
17. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
[TBL] [Abstract][Full Text] [Related]
18. [Cytoplasmic steroid hormone receptors in primary breast tumors].
Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV; Vishniakova VV
Vopr Onkol; 1982; 28(4):6-10. PubMed ID: 7090272
[TBL] [Abstract][Full Text] [Related]
19. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
[TBL] [Abstract][Full Text] [Related]
20. [What can be now expected of the determination of estrogen and progesterone receptors in the treatment of breast cancers].
Goussard J; Génot JY
Bull Cancer; 1994 Jan; 81(1):22-8. PubMed ID: 7949580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
